Trial Outcomes & Findings for Neuromodulatory Treatments for Pain Management in TBI (NCT NCT03418129)
NCT ID: NCT03418129
Last Updated: 2023-07-27
Results Overview
Measured by the Defense and Veterans Pain Rating Scale (DVPRS), a graphic tool to facilitate self-reported pain rating using a scale from 0-10, 0 being "no pain" to 10 being "as bad as it could be, nothing else matters."
COMPLETED
NA
254 participants
Baseline and 12 weeks
2023-07-27
Participant Flow
Participant milestones
| Measure |
Mobile App Mindfulness
Participants engage in the use of a mobile application on an iPod Touch for a minimum of 10 minutes a day, 4 days a week for a total of 12 weeks.
Mindfulness: Neuromodulatory intervention for pain management
|
Mobile App Neurofeedback
Participants engage in use of a mobile application on an iPod Touch for a minimum of 10 minutes a day, 4 days a week for a total of 12 weeks.
Neurofeedback: Neuromodulatory intervention for pain management
|
Mobile App Relaxation
Participants engage in use of a mobile application on an iPod Touch for a minimum of 10 minutes a day, 4 days a week for a total of 12 weeks.
Relaxation: Neuromodulatory intervention for pain management
|
|---|---|---|---|
|
Overall Study
STARTED
|
84
|
85
|
85
|
|
Overall Study
COMPLETED
|
70
|
59
|
66
|
|
Overall Study
NOT COMPLETED
|
14
|
26
|
19
|
Reasons for withdrawal
| Measure |
Mobile App Mindfulness
Participants engage in the use of a mobile application on an iPod Touch for a minimum of 10 minutes a day, 4 days a week for a total of 12 weeks.
Mindfulness: Neuromodulatory intervention for pain management
|
Mobile App Neurofeedback
Participants engage in use of a mobile application on an iPod Touch for a minimum of 10 minutes a day, 4 days a week for a total of 12 weeks.
Neurofeedback: Neuromodulatory intervention for pain management
|
Mobile App Relaxation
Participants engage in use of a mobile application on an iPod Touch for a minimum of 10 minutes a day, 4 days a week for a total of 12 weeks.
Relaxation: Neuromodulatory intervention for pain management
|
|---|---|---|---|
|
Overall Study
Lost to Follow-up
|
11
|
20
|
15
|
|
Overall Study
Withdrawal by Subject
|
3
|
6
|
4
|
Baseline Characteristics
Neuromodulatory Treatments for Pain Management in TBI
Baseline characteristics by cohort
| Measure |
Mobile App Mindfulness
n=84 Participants
Participants engage in the use of a mobile application on an iPod Touch for a minimum of 10 minutes a day, 4 days a week for a total of 12 weeks.
Mindfulness: Neuromodulatory intervention for pain management
|
Mobile App Neurofeedback
n=85 Participants
Participants engage in use of a mobile application on an iPod Touch for a minimum of 10 minutes a day, 4 days a week for a total of 12 weeks.
Neurofeedback: Neuromodulatory intervention for pain management
|
Mobile App Relaxation
n=85 Participants
Participants engage in use of a mobile application on an iPod Touch for a minimum of 10 minutes a day, 4 days a week for a total of 12 weeks.
Relaxation: Neuromodulatory intervention for pain management
|
Total
n=254 Participants
Total of all reporting groups
|
|---|---|---|---|---|
|
Age, Continuous
|
41.45 years
STANDARD_DEVIATION 8.78 • n=93 Participants
|
41.99 years
STANDARD_DEVIATION 9.27 • n=4 Participants
|
40.69 years
STANDARD_DEVIATION 8.63 • n=27 Participants
|
41.38 years
STANDARD_DEVIATION 8.88 • n=483 Participants
|
|
Sex: Female, Male
Female
|
13 Participants
n=93 Participants
|
20 Participants
n=4 Participants
|
17 Participants
n=27 Participants
|
50 Participants
n=483 Participants
|
|
Sex: Female, Male
Male
|
71 Participants
n=93 Participants
|
65 Participants
n=4 Participants
|
68 Participants
n=27 Participants
|
204 Participants
n=483 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
6 Participants
n=93 Participants
|
12 Participants
n=4 Participants
|
7 Participants
n=27 Participants
|
25 Participants
n=483 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
70 Participants
n=93 Participants
|
65 Participants
n=4 Participants
|
61 Participants
n=27 Participants
|
196 Participants
n=483 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
8 Participants
n=93 Participants
|
8 Participants
n=4 Participants
|
17 Participants
n=27 Participants
|
33 Participants
n=483 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
3 Participants
n=93 Participants
|
2 Participants
n=4 Participants
|
5 Participants
n=27 Participants
|
10 Participants
n=483 Participants
|
|
Race (NIH/OMB)
Asian
|
2 Participants
n=93 Participants
|
2 Participants
n=4 Participants
|
0 Participants
n=27 Participants
|
4 Participants
n=483 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
1 Participants
n=93 Participants
|
1 Participants
n=4 Participants
|
3 Participants
n=27 Participants
|
5 Participants
n=483 Participants
|
|
Race (NIH/OMB)
Black or African American
|
14 Participants
n=93 Participants
|
13 Participants
n=4 Participants
|
13 Participants
n=27 Participants
|
40 Participants
n=483 Participants
|
|
Race (NIH/OMB)
White
|
63 Participants
n=93 Participants
|
65 Participants
n=4 Participants
|
58 Participants
n=27 Participants
|
186 Participants
n=483 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=93 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=27 Participants
|
0 Participants
n=483 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
1 Participants
n=93 Participants
|
2 Participants
n=4 Participants
|
6 Participants
n=27 Participants
|
9 Participants
n=483 Participants
|
|
Region of Enrollment
United States
|
84 Participants
n=93 Participants
|
85 Participants
n=4 Participants
|
85 Participants
n=27 Participants
|
254 Participants
n=483 Participants
|
PRIMARY outcome
Timeframe: Baseline and 12 weeksPopulation: Participants who completed the DVPRS at 0 and 12 weeks.
Measured by the Defense and Veterans Pain Rating Scale (DVPRS), a graphic tool to facilitate self-reported pain rating using a scale from 0-10, 0 being "no pain" to 10 being "as bad as it could be, nothing else matters."
Outcome measures
| Measure |
Mobile App Mindfulness
n=75 Participants
Participants engage in the use of a mobile application on an iPod Touch for a minimum of 10 minutes a day, 4 days a week for a total of 12 weeks.
Mindfulness: Neuromodulatory intervention for pain management
|
Mobile App Neurofeedback
n=68 Participants
Participants engage in use of a mobile application on an iPod Touch for a minimum of 10 minutes a day, 4 days a week for a total of 12 weeks.
Neurofeedback: Neuromodulatory intervention for pain management
|
Mobile App Relaxation
n=76 Participants
Participants engage in use of a mobile application on an iPod Touch for a minimum of 10 minutes a day, 4 days a week for a total of 12 weeks.
Relaxation: Neuromodulatory intervention for pain management
|
|---|---|---|---|
|
Change in Self-reported Pain Intensity
|
-1.02 score on a scale
Standard Deviation 1.32
|
-0.78 score on a scale
Standard Deviation 1.27
|
-1.03 score on a scale
Standard Deviation 1.36
|
SECONDARY outcome
Timeframe: 0 and 12 weeksPopulation: EEG measurement was discontinued in March 2020 due to the COVID pandemic. Data not collected on 127 participants.
Average FFT (Fast Fourier Transform) Power (alpha 8-12 Hz) measured as sqrt(uV)/Hz.
Outcome measures
| Measure |
Mobile App Mindfulness
n=41 Participants
Participants engage in the use of a mobile application on an iPod Touch for a minimum of 10 minutes a day, 4 days a week for a total of 12 weeks.
Mindfulness: Neuromodulatory intervention for pain management
|
Mobile App Neurofeedback
n=43 Participants
Participants engage in use of a mobile application on an iPod Touch for a minimum of 10 minutes a day, 4 days a week for a total of 12 weeks.
Neurofeedback: Neuromodulatory intervention for pain management
|
Mobile App Relaxation
n=43 Participants
Participants engage in use of a mobile application on an iPod Touch for a minimum of 10 minutes a day, 4 days a week for a total of 12 weeks.
Relaxation: Neuromodulatory intervention for pain management
|
|---|---|---|---|
|
Change in EEG Alpha Power
|
-0.21 sqrt(uV)/Hz
Standard Deviation 0.40
|
-0.1 sqrt(uV)/Hz
Standard Deviation 0.41
|
-0.07 sqrt(uV)/Hz
Standard Deviation 0.35
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Baseline and 24 weeksPopulation: Participants who completed the DVPRS at baseline, 12 weeks, and 24 weeks.
Measured by the Defense and Veterans Pain Rating Scale (DVPRS), a graphic tool to facilitate self-reported pain rating using a scale from 0-10, 0 being "no pain" to 10 being "as bad as it could be, nothing else matters." This mean difference represents the mean change in pain intensity between 0 and 24 weeks. Please note that the analysis of results utilized a multilevel modeling (MLM) approach of all available data, which involved analyzing pain intensity data collected at 0, 12, and 24 weeks.
Outcome measures
| Measure |
Mobile App Mindfulness
n=71 Participants
Participants engage in the use of a mobile application on an iPod Touch for a minimum of 10 minutes a day, 4 days a week for a total of 12 weeks.
Mindfulness: Neuromodulatory intervention for pain management
|
Mobile App Neurofeedback
n=58 Participants
Participants engage in use of a mobile application on an iPod Touch for a minimum of 10 minutes a day, 4 days a week for a total of 12 weeks.
Neurofeedback: Neuromodulatory intervention for pain management
|
Mobile App Relaxation
n=63 Participants
Participants engage in use of a mobile application on an iPod Touch for a minimum of 10 minutes a day, 4 days a week for a total of 12 weeks.
Relaxation: Neuromodulatory intervention for pain management
|
|---|---|---|---|
|
Change in Self-reported Pain Intensity
|
-1.22 score on a scale
Standard Deviation 1.73
|
-0.98 score on a scale
Standard Deviation 1.36
|
-0.86 score on a scale
Standard Deviation 1.56
|
Adverse Events
Mobile App Mindfulness
Mobile App Neurofeedback
Mobile App Relaxation
Serious adverse events
| Measure |
Mobile App Mindfulness
n=84 participants at risk
Participants engage in the use of a mobile application on an iPod Touch for a minimum of 10 minutes a day, 4 days a week for a total of 12 weeks.
Mindfulness: Neuromodulatory intervention for pain management
|
Mobile App Neurofeedback
n=85 participants at risk
Participants engage in use of a mobile application on an iPod Touch for a minimum of 10 minutes a day, 4 days a week for a total of 12 weeks.
Neurofeedback: Neuromodulatory intervention for pain management
|
Mobile App Relaxation
n=85 participants at risk
Participants engage in use of a mobile application on an iPod Touch for a minimum of 10 minutes a day, 4 days a week for a total of 12 weeks.
Relaxation: Neuromodulatory intervention for pain management
|
|---|---|---|---|
|
Cardiac disorders
Cardiac Arrest
|
1.2%
1/84 • 24 weeks
|
0.00%
0/85 • 24 weeks
|
0.00%
0/85 • 24 weeks
|
|
General disorders
Anxiety
|
1.2%
1/84 • 24 weeks
|
0.00%
0/85 • 24 weeks
|
1.2%
1/85 • 24 weeks
|
|
General disorders
Dizziness
|
1.2%
1/84 • 24 weeks
|
0.00%
0/85 • 24 weeks
|
0.00%
0/85 • 24 weeks
|
|
General disorders
Headaches
|
2.4%
2/84 • 24 weeks
|
3.5%
3/85 • 24 weeks
|
1.2%
1/85 • 24 weeks
|
|
Blood and lymphatic system disorders
Blood Clot
|
0.00%
0/84 • 24 weeks
|
1.2%
1/85 • 24 weeks
|
0.00%
0/85 • 24 weeks
|
|
General disorders
Hospitalization
|
0.00%
0/84 • 24 weeks
|
1.2%
1/85 • 24 weeks
|
1.2%
1/85 • 24 weeks
|
|
General disorders
Suicidality
|
0.00%
0/84 • 24 weeks
|
1.2%
1/85 • 24 weeks
|
0.00%
0/85 • 24 weeks
|
Other adverse events
| Measure |
Mobile App Mindfulness
n=84 participants at risk
Participants engage in the use of a mobile application on an iPod Touch for a minimum of 10 minutes a day, 4 days a week for a total of 12 weeks.
Mindfulness: Neuromodulatory intervention for pain management
|
Mobile App Neurofeedback
n=85 participants at risk
Participants engage in use of a mobile application on an iPod Touch for a minimum of 10 minutes a day, 4 days a week for a total of 12 weeks.
Neurofeedback: Neuromodulatory intervention for pain management
|
Mobile App Relaxation
n=85 participants at risk
Participants engage in use of a mobile application on an iPod Touch for a minimum of 10 minutes a day, 4 days a week for a total of 12 weeks.
Relaxation: Neuromodulatory intervention for pain management
|
|---|---|---|---|
|
General disorders
Drowsiness
|
23.8%
20/84 • 24 weeks
|
20.0%
17/85 • 24 weeks
|
18.8%
16/85 • 24 weeks
|
|
General disorders
Irritability
|
2.4%
2/84 • 24 weeks
|
15.3%
13/85 • 24 weeks
|
15.3%
13/85 • 24 weeks
|
|
General disorders
Suicidal Ideation
|
2.4%
2/84 • 24 weeks
|
1.2%
1/85 • 24 weeks
|
10.6%
9/85 • 24 weeks
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place